APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,867 | -67.8% | 75,355 | +42.7% | 0.00% | – |
| Q2 2023 | $77,124 | -28.4% | 52,825 | 0.0% | 0.00% | – |
| Q1 2023 | $107,763 | +88230.3% | 52,825 | 0.0% | 0.00% | – |
| Q4 2022 | $122 | -99.9% | 52,825 | -0.3% | 0.00% | – |
| Q3 2022 | $161,000 | -14.8% | 52,961 | 0.0% | 0.00% | – |
| Q2 2022 | $189,000 | -38.8% | 52,961 | +0.4% | 0.00% | – |
| Q1 2022 | $309,000 | -1.3% | 52,727 | +32.5% | 0.00% | – |
| Q4 2021 | $313,000 | -49.2% | 39,807 | -0.3% | 0.00% | – |
| Q3 2021 | $616,000 | -29.4% | 39,924 | +2.6% | 0.00% | – |
| Q2 2021 | $872,000 | -20.1% | 38,917 | +8.8% | 0.00% | – |
| Q1 2021 | $1,091,000 | +5.6% | 35,762 | +26.8% | 0.00% | – |
| Q4 2020 | $1,033,000 | +1175.3% | 28,212 | +163.5% | 0.00% | – |
| Q3 2020 | $81,000 | -9.0% | 10,705 | 0.0% | 0.00% | – |
| Q2 2020 | $89,000 | +134.2% | 10,705 | +3.8% | 0.00% | – |
| Q1 2020 | $38,000 | – | 10,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,334,169 | $440,276 | 0.32% |
| ARMISTICE CAPITAL, LLC | 1,235,000 | $407,550 | 0.01% |
| Divergent Wealth Advisors | 10,000 | $3,300 | 0.00% |
| FIFTH THIRD BANCORP | 291 | $96 | 0.00% |
| FRANKLIN RESOURCES INC | 10,997 | $3,629 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $2 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 142 | $47 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,562 | $515 | 0.00% |
| NORTHERN TRUST CORP | 14,121 | $4,660 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |